Organometallic Ligands

<p>Sevoflurane is an experimental drug that belongs to the group of intravenous anaesthetics. It has been shown to be effective in the prevention and treatment of myocardial infarcts. Sevoflurane inhibits polymerase chain reaction by binding to dinucleotide phosphate, which prevents DNA synthesis. It also inhibits oxidative injury in the heart, as well as genotoxic activity. Sevoflurane is a potent chemical inhibitor of the ryanodine receptor, which regulates calcium release from the sarcoplasmic reticulum. This inhibition results in reduced contractility and relaxation of vascular smooth muscle cells, leading to vasodilation and increased blood flow.</p>

<p>Please enquire for more information about S55746 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>2,4-Dihydroxy-6-[(14R)-14-hydroxypentadecyl]benzoic acid is a specialized hydroxybenzoic acid derivative, typically identified as an antibacterial agent, which is derived from specific bacterial sources. This compound is characterized by its unique structure, containing both dihydroxy benzene rings and a lengthy aliphatic side chain. The origin of this compound is rooted in certain bacterial metabolic processes, often from strains that reside in specific ecological niches where they fend off competing microorganisms.</p>

<p>Mbp, gst tagged human is a recombinant fusion protein designed for molecular and biochemical research. It is derived from a human source and engineered by fusing the maltose-binding protein (MBP) with the human sequence of interest, alongside a glutathione S-transferase (GST) tag. This configuration allows for dual-affinity purification and enhances solubility, ultimately facilitating the study and manipulation of the target protein.</p>

<p>ARQ 621 is a highly specialized molecular compound, primarily utilized as a selective inhibitor. It originates from a complex synthetic process involving advanced organic chemistry techniques. Its mode of action involves targeting specific enzymatic pathways, thereby inhibiting their activity at a molecular level. This allows for precise modulation of biochemical processes, offering unprecedented control in experimental settings.</p>

<p>25-Hydroxy vitamin D3 3,3'-biotinylaminopropyl ether is a synthesized compound, which is an analog designed for specific biochemical applications. It is derived from 25-Hydroxyvitamin D3, an active form of vitamin D found in the human body, combined with a biotin moiety through a flexible linker. The mode of action involves the binding of the biotin component to avidin or streptavidin, facilitating the targeted delivery and study of vitamin D3 pathways. This compound allows for the exploration of vitamin D3 interactions and mechanisms by enabling easy tracking and manipulation.</p>

<p>TAS4464 is a digital-input class-D audio amplifier, developed as an integrated circuit with advanced signal processing capabilities. It originates from the semiconductor industry, utilizing precision engineering to enhance audio signal fidelity and power efficiency. The TAS4464 employs a modulated pulse width modulation (PWM) technique to amplify digital audio signals, ensuring minimal distortion and high output efficiency across various load conditions and frequencies.</p>

<p>16:1 Aldehyde-d5 is a deuterated aldehyde, which is a type of organic compound where the hydrogen atoms have been replaced with deuterium, an isotope of hydrogen. This modification is typically synthesized through isotopic exchange reactions or by using deuterated precursors. The use of deuterium labels in such compounds provides unique insights due to the slight differences in nuclear properties compared to protium, which enables enhanced analytical capabilities.</p>

<p>PKI 402 is a potent enzyme inhibitor, which is derived synthetically to target specific kinase activities. The product's source involves sophisticated chemical synthesis techniques designed to enhance selectivity and potency. PKI 402 functions primarily by modulating protein kinase activities, inhibiting phosphorylation processes crucial in cell signaling pathways.</p>

<p>MG 624 is a biofungicide, which is derived from naturally occurring microorganisms with a complex enzymatic mode of action. This product employs a consortium of beneficial microbes that produce enzymes capable of degrading the cell walls of various plant pathogens, thus preventing their spread and growth.</p>

<p>Tulrampator is a selective AMPA receptor potentiator, which is a synthetic pharmaceutical compound designed to enhance glutamatergic neurotransmission efficacy. This compound acts on the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in the central nervous system. Tulrampator modulates these receptors by increasing their response to endogenous glutamate, thus facilitating synaptic transmission and plasticity.</p>

<p>LE 300 is a cutting-edge biopesticide, which is derived from naturally occurring microbial sources. This formulation exploits the bioactive compounds produced by specific microorganisms to disrupt the physiological processes of target pests. The mode of action involves the inhibition of essential metabolic pathways, leading to the eventual mortality of these pests. This mechanism makes it an effective tool in integrated pest management programs that aim to minimize chemical pesticide use.</p>

<p>Antagonist of CGRP receptor</p>

<p>Diflumidone is a fungicide, which is a synthetic chemical compound with specific activity against pathogenic fungi. It is derived from chemical synthesis processes aimed at disrupting crucial metabolic pathways within fungal cells. The mode of action of diflumidone is primarily through disrupting mitochondrial function, specifically by inhibiting the electron transport chain. This interruption in cellular respiration leads to energy depletion and subsequent fungal cell death.</p>

<p>Atenolol is a selective beta blocker with antihypertensive activity. It selectively binds to the beta-1 adrenergic receptors of the vascular smooth muscles and the heart and blocks the release of certain chemicals in our body that might cause an increase in the blood pressure.</p>

<p>Pglu-Pro-Arg-mna monoacetate is a synthetic peptide inhibitor, which is typically derived from biochemical synthesis processes involving solid-phase peptide synthesis. Its primary mode of action is the competitive inhibition of certain enzyme activities, commonly within the realm of proteolytic enzymes. By mimicking substrate structures, it effectively binds to the enzyme's active site, thereby preventing the actual substrate from interacting and consequently inhibiting the enzyme's activity.</p>

<p>RG-12525 is an engineered compound designed for targeted genetic modification, which is synthesized from recombinant DNA technology. With precise gene-editing capabilities, it utilizes CRISPR-Cas9 as its mode of action, enabling specific gene sequences to be accurately cut and modified within a variety of eukaryotic cells. The compound's mechanism involves guiding RNA that pairs with target DNA sequences, allowing the Cas9 enzyme to introduce double-strand breaks, which facilitate desired genetic alterations through cellular repair pathways.<br><br>This compound is utilized predominantly in genetic engineering and functional genomics studies. RG-12525 enhances the ability to investigate gene function, develop gene therapies, and create genetically modified organisms for research purposes. Its applications extend to agricultural biotechnology, where it aids in the development of crops with enhanced traits, and to biomedical research, where it contributes to the understanding of genetic diseases and the development of potential treatments.</p>

<p>MMK 1 is a synthetic small molecule compound designed for use in cellular biology, specifically targeting signal transduction pathways. It is derived from innovative biotechnological synthesis, utilizing advanced techniques in organic chemistry to ensure high purity and stability. MMK 1 acts by modulating specific kinases involved in the regulation of cellular processes, affecting pathways critical for cell proliferation and differentiation.</p>

<p>Benzyl 3-fluoro-4-(3-oxopyrrolidin-1-yl)phenylcarbamate is a synthetic carbamate derivative, which is derived from the combination of fluorinated aromatic structures and pyrrolidinone rings. The compound is designed to act on biological systems by leveraging the unique properties of its fluorine and carbamate constituents. Fluorine's electronegativity can alter the compound's pharmacokinetics, while the carbamate moiety offers potential reactivity with enzymatic or cellular targets.</p>

<p>5-(4-Methoxyphenyl)-N-(1-methyl-4-(3-pyridinyl)butyl)-2,4-decadienamide is a bioactive compound derived from specific plant sources. This chemical entity functions primarily through modulation of biological pathways, notably influencing signal transduction and cellular responses. Its mode of action involves interaction with specific receptors and enzymes, affecting processes such as inflammation and neural activities.</p>

<p>Tomivosertib hydrochloride is an investigational small molecule inhibitor targeting the mitogen-activated protein kinase interacting kinase (MNK) pathway, which is a synthetic product derived from chemical synthesis. Its mode of action involves the selective inhibition of MNK1 and MNK2 enzymes, leading to the disruption of the phosphorylation of eIF4E, a key component in the translation initiation process. This interruption suppresses the production of oncogenic proteins involved in tumor growth and metastasis.</p>

<p>Tesevatinib is a kinase inhibitor, which is a type of pharmaceutical compound. It is derived from complex chemical synthesis, focusing on selectively inhibiting certain signaling pathways involved in cellular proliferation and survival. Tesevatinib exhibits its mode of action by targeting multiple tyrosine kinases, including epidermal growth factor receptor (EGFR) and others involved in oncogenic signaling. This multi-targeted approach aims to interrupt abnormal signaling cascades that promote tumor growth and metastasis.</p>

<p>ML-099 is a synthetic organometallic catalyst, which is derived from a complex metal-ligand framework. It operates through the facilitation of electron transfer processes, enhancing the reaction rates in catalytic cycles. This organometallic compound effectively lowers the activation energy, thereby accelerating chemical transformations and improving yield in various synthesis pathways.</p>

<p>Bestatin trifluoroacetate is an aminopeptidase inhibitor, which is sourced from the fermentation products of the Streptomyces species. Its mode of action involves the competitive inhibition of aminopeptidases, specifically targeting enzymes like aminopeptidase B and leukotriene A4 hydrolase. This inhibitory action results in the modulation of peptide-related processes within the cell, affecting the degradation of peptides into amino acids.</p>

<p>Dopamine (D1) receptor agonist</p>

<p>GSK726701A is an investigational biologic product that is a human monoclonal antibody, which is derived from recombinant DNA technology. The mode of action involves targeting and inhibiting specific pathways in the immune system that are responsible for allergic reactions. This is achieved by binding to and neutralizing specific cytokines or receptors involved in the inflammatory response, thus alleviating allergy symptoms.</p>

<p>LY 266097 Hydrochloride is a selective 5-HT2A receptor antagonist, which is a synthetic compound primarily used in neuroscience research. This compound is derived from laboratory synthesis, designed to interact specifically with serotonin receptors located in the central nervous system.</p>

<p>Cathepsin Inhibitor 1 is a selective chemical inhibitor specifically targeting cathepsin enzymes, which is derived through synthetic processes. Cathepsins are proteolytic enzymes predominantly found in lysosomes and play a crucial role in intracellular protein degradation. By inhibiting these enzymes, Cathepsin Inhibitor 1 effectively prevents the breakdown of protein substrates, thus allowing for the regulation of various cellular processes such as apoptosis, antigen presentation, and tissue remodeling.</p>

<p>GM 1489 is a synthetic glucocorticoid receptor agonist, which is a man-made compound mimicking naturally occurring steroid hormones. It is derived from chemical synthesis methods that facilitate precise structural modifications to enhance receptor affinity and efficacy. The mode of action of GM 1489 involves binding to cytoplasmic glucocorticoid receptors, leading to the translocation of the complex into the nucleus. This interaction results in the modulation of gene transcription, causing upregulation of anti-inflammatory proteins and downregulation of pro-inflammatory mediators.</p>

<p>Ethyl 2-(2-oxo-2H-chromen-7-yloxy)acetate is a synthetic coumarin derivative, often utilized in biochemical research. This compound is typically derived from the structural modification of naturally occurring coumarins, which are secondary metabolites found in many plant species. The modification process involves the introduction of an ethyl ester group, enhancing its stability and bioavailability compared to its natural counterparts.</p>

<p>1-(3-Chloro-2-pyridinyl)-N-cyclopentyl-4-methyl-5-(3-pyridinyl)-1H-pyrazole-3-methanamine is a selective antagonist, predominantly utilized in scientific research. This compound is synthetically derived through advanced organic chemistry techniques and is notable for its specificity and affinity towards particular receptor sites.</p>

<p>Ly2444296, also known as FP3FBZ, is an experimental pharmaceutical compound, specifically a small-molecule antagonist designed to target a particular receptor system in the central nervous system. It is synthesized through a complex series of chemical reactions, leveraging advanced organic synthesis techniques. The primary mode of action for Ly2444296 is the selective inhibition of the norepinephrine transporter (NET), which results in increased levels of norepinephrine in the synaptic cleft. This modulation of neurotransmitter dynamics can have significant effects on mood and stress responses.</p>

<p>BAY 6035 is an anticoagulant drug, which is a synthetic compound developed for clinical and research purposes. It is derived from chemical synthesis, designed to interact specifically with elements of the coagulation cascade. BAY 6035 functions by inhibiting factor Xa, an enzyme critical in the pathway leading to the formation of thrombin. By targeting factor Xa, it effectively reduces thrombin generation, consequently decreasing fibrin formation and clot development.</p>

<p>(R)-(-)-Ibuprofen-d3 is a stable isotope-labeled compound, specifically a deuterated form of the (R)-enantiomer of ibuprofen. This compound is synthesized through specific chemical processes, involving the replacement of hydrogen atoms with deuterium in the ibuprofen molecule. The presence of deuterium enhances the compound’s utility in various scientific applications by allowing researchers to better trace and study metabolic pathways without altering the compound’s inherent biological activity.</p>

<p>BMS-1166 is a small molecule immunotherapy agent that functions as a PD-1 antagonist. It is derived from targeted drug design, focusing on disrupting the interaction between the programmed cell death protein 1 (PD-1) and its ligands, PD-L1 and PD-L2.</p>

<p>Crkl, His tagged human is a recombinant fusion protein, which is sourced from engineered human cells. It is designed to include a histidine tag, facilitating affinity purification and detection in research applications. This protein acts as an adaptor in intracellular signaling pathways, primarily involved in the transduction of extracellular signals into cellular responses. It plays a crucial role in various biological processes, including cell proliferation, migration, and differentiation, by interacting with other proteins and initiating downstream signaling cascades.</p>

<p>Tiaprost is a synthetic analogue of prostaglandin F2α that has been used in animal health and fertility. This drug stimulates follicular growth and ovulation in cows and heifers, as well as increases estradiol benzoate (EB) levels in the blood. Tiaprost is also used to treat intrauterine infections caused by bacteria, such as E. coli, or protozoa, such as Tritrichomonas foetus. Tiaprost has been shown to be clinically relevant for the treatment of human infertility due to its ability to stimulate ovulation in women with polycystic ovary syndrome (PCOS).</p>

<p>16:0 Cyanur pe is a synthetic phospholipid compound, which is derived from saturated fatty acids. This substance is primarily utilized in the field of lipidomics as a part of phospholipid membrane studies. With its unique structure, it facilitates the exploration of lipid interactions within biological membranes and can serve as a probe in biophysical experiments.</p>

<p>6-[[4-(2-Fluorophenyl)-1-piperazinyl]methyl]-N2-1-naphthalenyl-1,3,5-triazine-2,4-diamine is a synthetic triazine compound, which is an intriguing molecule in the field of medicinal chemistry. Triazines are heterocyclic compounds known for their diverse pharmacological properties. This specific compound originates from the inclusion of a piperazine group, a 2-fluorophenyl moiety, and a naphthalenyl structure, which collectively contribute to its unique chemical characteristics.</p>

<p>Mv-1-NH-Me is a synthetic peptide, which is derived from laboratory synthesis rather than a natural source. Its design is often based on modifying naturally occurring peptides to achieve specific biochemical properties. The mode of action typically involves interaction with specific proteins or cell receptors, altering their natural state or activity, which can help elucidate biological pathways or mechanisms.</p>

<p>08:0 Pi(3)P is a synthetic phosphatidylinositol 3-phosphate analog, which is often utilized as a biochemical tool. This product is derived from phosphatidylinositol, a lipid naturally occurring within biological membranes, and is chemically synthesized to mimic the function of the native lipid. Its mode of action involves binding to specific phosphoinositide-binding domains within proteins, allowing researchers to study protein-lipid interactions and signaling pathways.</p>

<p>Laniquidar is a pharmacological agent classified as a third-generation multidrug resistance (MDR) modulator. It is derived from a class of compounds specifically designed to overcome MDR in cancer by targeting P-glycoprotein, a well-known efflux transporter protein. Laniquidar functions by inhibiting the action of P-glycoprotein, which is often overexpressed in various cancer cells and facilitates the efflux of chemotherapeutic drugs, thereby reducing their intracellular concentrations and effectiveness.</p>

<p>2,3-Dihydroxypropyl (8Z)-8-heptadecenoate is a synthetic ester compound often utilized in biochemical research and lipid metabolism studies. This compound is derived through the esterification of 2,3-dihydroxypropanol with (8Z)-8-heptadecenoic acid, typically sourced from advanced chemical synthesis processes. Its mode of action involves participating in lipid pathways as a biochemical mimic, providing insights into enzymatic activities and metabolic regulation associated with lipid molecules.</p>

<p>1-Hydroxy-2,3,5-trimethoxyxanthone is a xanthone derivative, which is a class of compounds known for their diverse biological activities. This compound is typically sourced from various plant species, particularly those within the Gentianaceae family. It is often isolated using advanced extraction techniques such as solvent extraction followed by chromatographic purification.</p>

<p>3-[(1R,5S)-8-[2-[Cyclohexylmethyl(2,3-dihydroxypropanoyl)amino]ethyl]-8-azabicyclo[3.2.1]octan-3-yl]benzamide is a selective inhibitor that is synthesized for its pharmacological properties. This compound is typically derived through complex organic synthesis involving the modification of bicycle and benzamide frameworks to achieve specificity and potency in its action.</p>

<p>Oxcarbazepine is an anti-epileptic drug that is used for the treatment of partial-onset seizures. Although, the mechanism of action for this drug is unclear, it is said to involve the blockage of voltage-gated sodium channels. As a result, the firing of the action potentials which lead to seizures are reduced and so seizure activity is inhibited.</p>

<p>GSK'963 is a selective inhibitor, which is a pharmacological agent primarily targeting the receptor-interacting protein kinase 1 (RIP1). Originating from GlaxoSmithKline's research efforts, this inhibitor is a synthetic compound designed to interfere with specific biochemical pathways. GSK'963 operates by targeting the RIP1 kinase, a crucial component involved in necroptosis, a form of programmed cell death distinct from apoptosis.</p>

<p>3-[[2-(Cyclopentylamino)-3,4-dioxo-1-cyclobuten-1-yl]amino]-2-hydroxy-N-methylbenzamide is a potent enzyme inhibitor, which is synthetically derived with high specificity for certain protein interactions. Its mode of action involves the inhibition of targeted enzymatic activity, potentially modulating biochemical pathways of interest in various scientific studies.</p>

<p>Pd 128907 is a selective agonist that targets the A2A adenosine receptor, which is a G protein-coupled receptor critical in numerous physiological processes. This compound is originally synthesized through a chemical synthesis process that involves precise structural engineering to ensure specificity to the A2A receptor subtype. Its mode of action involves binding to the receptor and mimicking the effects of adenosine, which results in modulation of downstream signaling pathways.</p>

<p>BC-LI-0186 is a microbial inoculant, which is a blend of beneficial microbes derived from natural soil environments with symbiotic relationships with plants. The mode of action involves colonization of the rhizosphere and the enhancement of nutrient uptake by solubilizing phosphates and fixing atmospheric nitrogen. Additionally, it facilitates the production of growth-promoting substances such as auxins and cytokinins.</p>

<p>L002 is a chemical inhibitor that targets lysine acetyltransferases (KATs), which are enzymes responsible for the acetylation of lysine residues on histone and non-histone proteins. This small-molecule inhibitor is derived from a synthetic chemical source utilizing rational design principles to enhance its specificity and efficacy. The mode of action of L002 involves the competitive inhibition of the KATs catalytic activity, which leads to a reduction in protein acetylation levels. This alteration affects chromatin structure and function, thereby influencing gene expression and cellular processes such as proliferation and differentiation.</p>

<p>RPH-2823 is a cutting-edge biochemical reagent, meticulously synthesized through advanced organic chemistry processes. This compound is derived from a series of complex reactions involving proprietary modifications to enhance its stability and reactivity under physiological conditions. The intricate mode of action of RPH-2823 involves targeting specific biochemical pathways, allowing for precise interaction at the molecular level with target receptors or enzymes. It exhibits strong affinity and selectivity, making it a valuable tool in modulating biological activities. RPH-2823 finds extensive applications in biochemical research, particularly within cellular signaling and metabolic pathway studies. It serves as an indispensable resource for unraveling complex biological mechanisms, facilitating the identification and characterization of potential therapeutic targets. Scientists utilize RPH-2823 to gain insights into cellular processes, offering the potential for groundbreaking discoveries in pharmacology and biotechnology.</p>

<p>MPI-0479605 is a small molecule inhibitor, specifically designed to target and inhibit the activity of certain protein kinases. It is synthetically derived and formulated to interact with key signaling pathways involved in cellular growth and proliferation. The compound works by selectively binding to the ATP-binding site of the targeted kinases, thereby preventing their phosphorylation activity. This interaction disrupts downstream signaling pathways, ultimately influencing cellular functions such as differentiation, apoptosis, and migration.</p>

<p>CCG-222740 is a small molecule inhibitor, which is derived from synthetic chemistry advancements aimed at developing targeted cancer therapies. It operates by modulating specific signaling pathways that are known to contribute to tumor growth and survival. Specifically, CCG-222740 targets the Rho GTPase family, which is involved in regulating cytoskeletal dynamics and cell proliferation.</p>

<p>2-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran is a synthetic benzofuran derivative, which is a compound often used in a range of biochemical applications. This compound is typically sourced through chemical synthesis, involving specific reactions that introduce iodine atoms into the structural configuration of the benzofuran framework. Its mode of action primarily revolves around its interaction with thyroid-related pathways, due to the presence of iodine atoms — an essential element in thyroid hormone synthesis and function.</p>

<p>42-(2-Tetrazolyl)rapamycin is an immunophilin-binding compound, which is derived from the natural product rapamycin. It is a semi-synthetic derivative designed to enhance the properties of the parent compound. As a macrolide, it is sourced from a bacterium called *Streptomyces hygroscopicus*. The mode of action involves binding to FKBP12, forming a complex that inhibits the mammalian target of rapamycin (mTOR), a critical kinase in cell growth, proliferation, and survival pathways.</p>

<p>ASP 4058 is a metallo-β-lactamase inhibitor, which is derived from synthetic sources and designed to counteract the resistance mechanisms of β-lactam antibiotics. The compound operates by binding to and inhibiting metallo-β-lactamase enzymes, which are responsible for hydrolyzing and inactivating the β-lactam ring of antibiotics, rendering them ineffective against resistant bacterial strains.</p>

<p>UNC10217938A is a synthetic small molecule serving as a histone deacetylase (HDAC) inhibitor, which is designed through extensive medicinal chemistry optimization. This compound originates from research-based laboratories focused on epigenetic regulation and its implications in cellular processes. The mode of action involves selective inhibition of HDAC enzymes, leading to increased acetylation of histone proteins. This alteration in the acetylation status affects the chromatin structure, ultimately influencing gene expression.</p>

<p>7-((Benzo[D]thiazol-2-ylamino)(4-(difluoromethoxy)phenyl)methyl)quinolin-8-ol is a synthetic investigational compound, which is typically synthesized in a laboratory setting through a series of chemical reactions involving quinoline derivatives and other complex organic molecules. This compound is designed to target and inhibit specific molecular pathways involved in cancer cell proliferation and survival. Its mode of action is believed to involve the disruption of signaling pathways critical to tumor growth, potentially through interaction with specific kinases or receptor sites on the cancer cells.</p>

<p>Almokalant is an investigational antiarrhythmic drug, which is a synthetic pharmaceutical compound. It is derived from the class of drugs known as selective potassium channel blockers. Almokalant's mode of action involves the blockade of hERG (human Ether-à-go-go-Related Gene) potassium channels. This blockade prolongs the cardiac action potential duration, which can be beneficial in stabilizing irregular heartbeats.</p>

<p>Please enquire for more information about S186 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>CPI-455 HCl is a potent, selective bromodomain inhibitor, which is a synthetic chemical compound designed to modulate epigenetic targets. Its source is a laboratory-synthesized small molecule developed to specifically inhibit the activity of bromodomains, which are protein domains that recognize acetylated lysine residues. The mode of action involves competitively binding to bromodomains, thereby preventing the interaction between these domains and acetylated histones. This inhibition disrupts the transcriptional activity of bromodomain-containing proteins and can alter gene expression patterns.</p>

<p>PD 173955-Analog1 is a synthetic small molecule inhibitor, which is derived from a class of tyrosine kinase inhibitors commonly used in biochemical research. It functions by targeting the ATP-binding site of tyrosine kinases, leading to the inhibition of kinase activity. This interruption of signaling pathways is crucial for understanding the biological processes involved in cell proliferation and oncogenesis.</p>

<p>Acat-in-1 cis isomer is an enzymatic inhibitor, which is synthesized through organic chemical processes. It is particularly known for its action as an inhibitor of acyl-coenzyme A:cholesterol acyltransferase (ACAT), an enzyme crucial for the esterification of cholesterol. This inhibition occurs through the specific binding to the active site of ACAT, preventing the conversion of cholesterol to cholesteryl esters, and thereby influencing the cholesterol metabolism pathways.</p>

<p>AZD7624 is an inhaled anti-inflammatory compound, which is derived from AstraZeneca's research efforts. It functions as a p38 MAP kinase inhibitor, targeting specific pathways involved in inflammatory responses within the respiratory system. AZD7624 is designed for the modulation of inflammatory processes in diseases such as chronic obstructive pulmonary disease (COPD) and asthma. By inhibiting the p38 MAP kinase, AZD7624 attenuates the production of pro-inflammatory cytokines and other mediators that contribute to the pathological progression of respiratory disorders. Its use is particularly significant in patients suffering from persistent inflammation where traditional therapies may be insufficient. The development of AZD7624 highlights the ongoing efforts to manage inflammatory diseases at the molecular level with a targeted therapeutic approach, providing insights into novel intervention strategies for respiratory illnesses.</p>

<p>Octadecanoic acid 1,1′-[(1R)-1-[[[hydroxy[2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]ethoxy]phosphinyl]oxy]methyl]-1,2-ethanediyl] ester ammonium salt is a synthetic phospholipid analog, which is often utilized in biochemical and cellular research. This compound is derived from modifications of natural lipids and is strategically designed to include a fluorescent group, enhancing its utility in various analytical applications. Its mode of action involves integrating into lipid membranes, serving as a marker for studying membrane dynamics and interactions due to the presence of the fluorescent nitrobenzoxadiazole (NBD) moiety.</p>

<p>PKI (5-24) is a synthetic peptide specifically designed as a protein kinase inhibitor. Derived from a segment of the endogenous PKA inhibitor protein, this peptide is utilized to inhibit the activity of cyclic AMP-dependent protein kinase (PKA). The sequence corresponds to amino acids 5-24 of the native protein, retaining its potent inhibitory activity. PKI (5-24) functions by binding to the catalytic subunit of PKA, thus preventing the phosphorylation of downstream targets.</p>

<p>I-Cbp 112 hydrochloride is a small molecule inhibitor that is synthetically derived. Its primary mode of action involves the selective inhibition of bromodomain-containing proteins, specifically targeting interactions between bromodomains and acetylated lysine residues on histone tails. This results in modulation of transcriptional regulation by interfering with the reader functions of bromodomains, thereby impacting chromatin remodeling and gene expression pathways.</p>

<p>VL285 is a biochemical compound designed as a specific enzyme inhibitor, derived from advanced synthetic chemistry processes. This compound functions by binding to the active site of the target enzyme, thereby preventing substrate interaction and subsequent catalytic activity. Its action is characterized by high specificity and potency, which allows for effective modulation of enzyme function without significant off-target effects.</p>

<p>GSK8814 is a pharmacological compound, specifically a selective receptor modulator, which is synthesized through advanced chemical engineering processes. This compound acts by selectively targeting specific receptors within biological systems, influencing cellular responses and signaling pathways. Its mode of action involves the modulation of receptor activity, offering precise control over physiological and biochemical processes. GSK8814 is predominantly used in both clinical research and therapeutic contexts, where it plays a crucial role in exploring the regulation of physiological responses. Its applications may include the investigation of receptor-mediated effects and the development of treatment paradigms for various disorders. By providing insights into receptor function, GSK8814 facilitates the expansion of knowledge in receptor biology and the advancement of targeted therapies.</p>

<p>C-82 is a synthetic chemical inhibitor, which is commonly sourced from laboratory-derived compounds and characterized through organic chemistry techniques. Its mode of action involves selective inhibition of specific enzymes or proteins within particular biochemical pathways, rendering it useful for dissecting complex biological systems. This specificity allows researchers to elucidate the roles of individual components within larger networks by observing downstream effects of inhibition.</p>

<p>Please enquire for more information about Prifuroline including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Valsartan-d3 is a deuterated version of valsartan, which is a pharmacological compound used for research purposes. This isotopically labeled compound is derived through the strategic substitution of hydrogen atoms with deuterium in the valsartan molecule. The incorporation of deuterium, a stable isotope of hydrogen, enhances the compound's utility in various scientific applications without altering its fundamental biological activity.</p>

<p>Pf-06412154 hydrochloride is an investigational anti-inflammatory agent, which is synthesized chemically. It functions as a selective inhibitor of Janus kinases (JAK), crucial enzymes involved in the signaling pathways of various cytokines and growth factors. By inhibiting JAK activity, Pf-06412154 disrupts the JAK-STAT pathway, which is implicated in the pathogenesis of several inflammatory and autoimmune disorders. This mode of action is intended to reduce the expression of inflammatory cytokines, offering potential therapeutic benefits.</p>

<p>Aspochalasin M is a natural product, specifically a cytochalasin, which is a secondary metabolite derived from fungi of the genus *Aspergillus*. Its mode of action involves the disruption of actin filament polymerization within the cytoskeleton. By binding to the barbed ends of actin filaments, Aspochalasin M effectively inhibits further monomer addition, leading to altered cellular morphology and impaired cellular processes such as division and motility.</p>

<p>DLK-IN-1 is a synthetic small-molecule inhibitor, which is a product derived from targeted chemical synthesis with the specific aim of modulating the function of certain kinases. This inhibitor is sourced through advanced laboratory techniques that allow for precision-targeting of proteins involved in cellular signaling pathways. DLK-IN-1 specifically inhibits the dual leucine zipper kinase (DLK), a protein kinase involved in neuronal regeneration and degeneration pathways. By binding to the ATP-binding site of DLK, it prevents the phosphorylation of downstream substrates, thus modulating the DLK-mediated signaling cascade.<br><br>The utilization of DLK-IN-1 primarily lies in neurological research, particularly in understanding and potentially mitigating neurodegenerative diseases and nerve injury responses. It is instrumental in studying the roles of DLK in axonal degeneration and regeneration, providing insights into therapeutic approaches for conditions like Alzheimer's, Parkinson's, and other neurodegenerative disorders. Researchers employ DLK-IN-1 to dissect the DLK signaling mechanism, aiming to discover novel intervention points within neuronal repair and deterioration processes. The specificity and action of DLK-IN-1 make it a crucial tool for probing deeper into the molecular underpinnings of nerve health and disease.</p>

<p>JNK Inhibitor V is a small molecule inhibitor, which is a synthetic compound with selective inhibitory activity against the c-Jun N-terminal kinase (JNK) pathway. It acts by specifically targeting the JNK enzymes, thereby blocking their interaction with downstream substrates involved in various cellular processes. The inhibition of JNK activity by JNK Inhibitor V mitigates the phosphorylation of c-Jun and other transcription factors, ultimately influencing gene expression and cellular responses.</p>

<p>NMDAR antagonist 1 is a chemical compound that functions as a non-competitive antagonist at the N-methyl-D-aspartate receptor (NMDAR), a subtype of glutamate receptor. Sourced synthetically, this compound is designed to modify neurotransmitter activity in the central nervous system by inhibiting the action of glutamate, which is the primary excitatory neurotransmitter. Its mode of action involves blocking the ion channel of the NMDAR, thereby preventing calcium ions from entering the neuron and modulating synaptic plasticity and neuronal communication.<br><br>This antagonist is widely used in neuroscience research to study the mechanisms of excitotoxicity, which is implicated in a variety of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). It is also utilized to explore the fundamental processes involving learning, memory, and synaptic transmission. By providing insights into glutamatergic signaling pathways, NMDAR antagonist 1 aids in the development of therapeutic strategies for conditions related to excessive neuronal activity and synaptic dysfunction.</p>

<p>WAY-262611 is a synthetic small-molecule compound, which is an experimental pharmacological agent originally sourced from chemical libraries aimed at modulating bone biology. This compound acts as an antagonist of the Wnt signaling pathway, specifically targeting low-density lipoprotein receptor-related protein 5 (LRP5). By inhibiting the binding of Wnt proteins, WAY-262611 modulates downstream signaling events, leading to alterations in gene expression that influence bone mass and density.</p>

<p>(E)-N-[(2S)-1-[5-[2-(4-Cyanoanilino)-4-(propylamino)pyrimidin-5-yl]pent-4-ynylamino]-1-oxopropan-2-yl]-4-(dimethylamino)-N-methylbut-2-enamide is a novel small molecule, which is a synthetic compound designed for research purposes. Its structure is derived from a combination of pyrimidine and aniline derivatives, engineered to enhance biological activity and specificity. This compound functions mainly as a kinase inhibitor, targeting specific signaling pathways involved in cellular proliferation and survival. By inhibiting kinase activity, it can modulate aberrant signal transduction pathways frequently observed in various pathological conditions, including cancers.</p>

<p>S107 hydrochloride is a pharmacological compound that functions as a stabilizer of the ryanodine receptor (RyR), which is a crucial channel in the sarcoplasmic reticulum involved in calcium ion regulation within muscle cells. This synthetic molecule originates from medicinal chemistry efforts aimed at modulating intracellular calcium handling, particularly in skeletal and cardiac muscle tissues.</p>

<p>TT 232 is an advanced semiconductor characterization instrument, which is a critical tool in the field of materials science and electrical engineering. This product is sourced from the latest innovations in semiconductor technology, designed to provide comprehensive analysis of material properties. With a sophisticated mode of action, TT 232 employs high-resolution electrical measurements to assess parameters such as carrier concentration, mobility, and defect levels within semiconductor materials.</p>

<p>2-((2,6-Dimethoxy-4-(2-methyl-1-oxo-1,2-dihydro-2,7-naphthyridin-4-yl)benzyl)(methyl)amino)-N-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethyl)acetamide is a synthetic bioactive compound, which is developed through intricate organic synthesis processes. This compound functions primarily through the modulation of specific molecular pathways, such as protein-protein interactions or enzyme activity, potentially altering cellular processes. It may exhibit properties that interfere with particular signaling cascades or molecular targets, thus influencing their biological outcomes.<br><br>The applications of this compound could span across various research domains, particularly in pharmacological studies where it may serve as an investigational tool to probe biological systems or as a lead compound in drug development efforts against diseases where its target pathways are implicated. Scientists in medicinal chemistry and pharmacology might find this compound especially relevant for experiments seeking novel therapeutic interventions or mechanistic insights into complex biological phenomena.</p>

<p>PF 04937319 is an investigative ophthalmic drug candidate, which is derived from chemical synthesis. It functions as an inhibitor of the Rho kinase enzyme. The Rho kinase pathway is critical in regulating aqueous humor outflow in the eye, and its inhibition reduces intraocular pressure, a primary risk factor for glaucoma.</p>

<p>2-Amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoic acid is a sophisticated organic compound, typically synthesized for scientific research purposes. It is derived through multi-step chemical processes that integrate functional groups to achieve its specific structure. This compound functions by interacting with biological targets at the molecular level, potentially influencing biochemical pathways and signaling mechanisms.</p>

<p>GLN-1062 is a prodrug, crafted to facilitate the enhanced delivery of glutathione precursors across the blood-brain barrier. It is sourced from the modification of existing compounds to improve central nervous system (CNS) penetration. The mode of action involves enzymatic conversion within the CNS, releasing active ingredients that support glutathione synthesis.</p>